Ignite Creation Date:
2025-12-24 @ 11:59 AM
Ignite Modification Date:
2025-12-28 @ 12:14 AM
Study NCT ID:
NCT01142661
Status:
COMPLETED
Last Update Posted:
2013-09-20
First Post:
2010-06-10
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Compassionate Use of Eribulin for the Treatment of Advanced Breast Cancer Refractory to All Other Marketed Therapies
Sponsor:
Eisai Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-08
Start Date Type:
None
Primary Completion Date:
2011-08
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2010-06-10
First Submit QC Date:
None
Study First Post Date:
2010-06-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-04-29
Results First Submit QC Date:
None
Results First Post Date:
2013-09-20
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-09-19
Last Update Post Date:
2013-09-20
Last Update Post Date Type:
ESTIMATED